Array Behavioral Care launched a new service to help providers assess patients with urgent behavioral health needs and ...
Since implementing AI clinical documentation improvement (CDI) tools, Intermountain has seen a 22% point increase in ...
HHS Secretary Robert F. Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force this week, completing ...
Ayble Health’s Series A round was led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic ...
Ultragenyx Pharmaceutical’s Fayuvi is now the first FDA-approved therapy for the underlying cause of Sanfilippo syndrome type ...
The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...
Trump’s $500 ACA refunds offer immediate financial relief to some enrollees, but healthcare experts question whether they address the broader affordability challenges facing Americans.
A growing group of companies is developing new immunology drugs to challenge Dupixent, the blockbuster Sanofi product with a dominating presence in multiple inflammatory indications. North Immunology ...
After a near-miss with her own breast cancer diagnosis, Ariel Ganz co-founded Arben Ventures, a precision health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results